1
|
Reppert SM and Weaver DR: Coordination of
circadian timing in mammals. Nature. 418:935–941. 2002. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ko CH and Takahashi JS: Molecular
components of the mammalian circadian clock. Hum Mol Genet. 15(Spec
No 2): R271–R277. 2006. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ceriani MF, Darlington TK, Staknis D, et
al: Light-dependent sequestration of TIMELESS by CRYPTOCHROME.
Science. 285:553–556. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
Benna C, Scannapieco P, Piccin A, et al: A
second timeless gene in Drosophila shares greater sequence
similarity with mammalian tim. Curr Biol. 10:R512–R513. 2000.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Matsuo T, Yamaguchi S, Mitsui S, Emi A,
Shimoda F and Okamura H: Control mechanism of the circadian clock
for timing of cell division in vivo. Science. 302:255–259. 2003.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Unsal-Kacmaz K, Mullen TE, Kaufmann WK and
Sancar A: Coupling of human circadian and cell cycles by the
timeless protein. Mol Cell Biol. 25:3109–3116. 2005. View Article : Google Scholar : PubMed/NCBI
|
7
|
Unsal-Kacmaz K, Chastain PD, Qu PP, et al:
The human Tim/Tipin complex coordinates an Intra-S checkpoint
response to UV that slows replication fork displacement. Mol Cell
Biol. 27:3131–3142. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Yang X, Wood PA and Hrushesky WJ:
Mammalian TIMELESS is required for ATM-dependent CHK2 activation
and G2/M checkpoint control. J Biol Chem. 285:3030–3034. 2010.
View Article : Google Scholar :
|
9
|
Barnes JW, Tischkau SA, Barnes JA, et al:
Requirement of mammalian Timeless for circadian rhythmicity.
Science. 302:439–442. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gotter AL, Manganaro T, Weaver DR, et al:
A time-less function for mouse timeless. Nat Neurosci. 3:755–756.
2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wood LD, Parsons DW, Jones S, et al: The
genomic landscapes of human breast and colorectal cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Fu L, Pelicano H, Liu J, Huang P and Lee
C: The circadian gene Period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Fu A, Leaderer D, Zheng T, Hoffman AE,
Stevens RG and Zhu Y: Genetic and epigenetic associations of
circadian gene TIMELESS and breast cancer risk. Mol Carcinog.
51:923–929. 2012. View
Article : Google Scholar
|
14
|
Mazzoccoli G, Panza A, Valvano MR, et al:
Clock gene expression levels and relationship with clinical and
pathological features in colorectal cancer patients. Chronobiol
Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Neumann O, Kesselmeier M, Geffers R, et
al: Methylome analysis and integrative profiling of human HCCs
identify novel protumorigenic factors. Hepatology. 56:1817–1827.
2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Lee MH and Surh YJ: eEF1A2 as a putative
oncogene. Ann NY Acad Sci. 1171:87–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Knudsen SM, Frydenberg J, Clark BF and
Leffers H: Tissue-dependent variation in the expression of
elongation factor-1 alpha isoforms: isolation and characterisation
of a cDNA encoding a novel variant of human elongation-factor 1
alpha. Eur J Biochem. 215:549–554. 1993. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lee S, Francoeur AM, Liu S and Wang E:
Tissue-specific expression in mammalian brain, heart, and muscle of
S1, a member of the elongation factor-1 alpha gene family. J Biol
Chem. 267:24064–24068. 1992.PubMed/NCBI
|
19
|
Ruest LB, Marcotte R and Wang E: Peptide
elongation factor eEF1A-2/S1 expression in cultured differentiated
myotubes and its protective effect against caspase-3-mediated
apoptosis. J Biol Chem. 277:5418–5425. 2002. View Article : Google Scholar
|
20
|
Schlaeger C, Longerich T, Schiller C, et
al: Etiology-dependent molecular mechanisms in human
hepatocarcinogenesis. Hepatology. 47:511–520. 2008. View Article : Google Scholar
|
21
|
Pellegrino R, Calvisi DF, Neumann O, et
al: EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent
stabilization of MDM4 in hepatocellular carcinoma. Hepatology.
59:1886–1899. 2014. View Article : Google Scholar
|
22
|
Pfaffl MW: A new mathematical model for
relative quantification in real-time RT-PCR. Nucleic Acids Res.
29:e452001. View Article : Google Scholar : PubMed/NCBI
|
23
|
Longerich T, Breuhahn K, Odenthal M,
Petmecky K and Schirmacher P: Factors of transforming growth factor
beta signalling are co-regulated in human hepatocellular carcinoma.
Virchows Arch. 445:589–596. 2004. View Article : Google Scholar : PubMed/NCBI
|
24
|
Straub BK, Boda J, Kuhn C, et al: A novel
cell-cell junction system: the cortex adhaerens mosaic of lens
fiber cells. J Cell Sci. 116:4985–4995. 2003. View Article : Google Scholar : PubMed/NCBI
|
25
|
Smith KD, Fu MA and Brown EJ: Tim-Tipin
dysfunction creates an indispensible reliance on the ATR-Chk1
pathway for continued DNA synthesis. J Cell Biol. 187:15–23. 2009.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Mao Y, Fu A, Leaderer D, Zheng T, Chen K
and Zhu Y: Potential cancer-related role of circadian gene TIMELESS
suggested by expression profiling and in vitro analyses. BMC
Cancer. 13:4982013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lin YM, Chang JH, Yeh KT, et al:
Disturbance of circadian gene expression in hepatocellular
carcinoma. Mol Carcinog. 47:925–933. 2008. View Article : Google Scholar : PubMed/NCBI
|
28
|
Leman AR, Noguchi C, Lee CY and Noguchi E:
Human Timeless and Tipin stabilize replication forks and facilitate
sister-chromatid cohesion. J Cell Sci. 123:660–670. 2010.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Scaggiante B, Dapas B, Bonin S, et al:
Dissecting the expression of EEF1A1/2 genes in human prostate
cancer cells: the potential of EEF1A2 as a hallmark for prostate
transformation and progression. Br J Cancer. 106:166–173. 2012.
View Article : Google Scholar :
|
30
|
Pinke DE and Lee JM: The lipid kinase
PI4KIIIbeta and the eEF1A2 oncogene co-operate to disrupt
three-dimensional in vitro acinar morphogenesis. Exp Cell Res.
317:2503–2511. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Pinke DE, Kalloger SE, Francetic T,
Huntsman DG and Lee JM: The prognostic significance of elongation
factor eEF1A2 in ovarian cancer. Gynecol Oncol. 108:561–568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Gross SR and Kinzy TG: Improper
organization of the actin cytoskeleton affects protein synthesis at
initiation. Mol Cell Biol. 27:1974–1989. 2007. View Article : Google Scholar :
|
33
|
Gross SR and Kinzy TG: Translation
elongation factor 1A is essential for regulation of the actin
cytoskeleton and cell morphology. Nat Struct Mol Biol. 12:772–778.
2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Amiri A, Noei F, Jeganathan S, Kulkarni G,
Pinke DE and Lee JM: eEF1A2 activates Akt and stimulates
Akt-dependent actin remodeling, invasion and migration. Oncogene.
26:3027–3040. 2007. View Article : Google Scholar
|
35
|
Jeganathan S and Lee JM: Binding of
elongation factor eEF1A2 to phosphatidylinositol 4-kinase beta
stimulates lipid kinase activity and phosphatidylinositol
4-phosphate generation. J Biol Chem. 282:372–380. 2007. View Article : Google Scholar
|
36
|
Khacho M, Mekhail K, Pilon-Larose K, Pause
A, Cote J and Lee S: eEF1A is a novel component of the mammalian
nuclear protein export machinery. Mol Biol Cell. 19:5296–5308.
2008. View Article : Google Scholar : PubMed/NCBI
|
37
|
Li D, Wei T, Abbott CM and Harrich D: The
unexpected roles of eukaryotic translation elongation factors in
RNA virus replication and pathogenesis. Microbiol Mol Biol Rev.
77:253–266. 2013. View Article : Google Scholar : PubMed/NCBI
|
38
|
Chuang SM, Chen L, Lambertson D, Anand M,
Kinzy TG and Madura K: Proteasome-mediated degradation of
cotranslationally damaged proteins involves translation elongation
factor 1A. Mol Cell Biol. 25:403–413. 2005. View Article : Google Scholar :
|